Journal Article (Review Article)

DKFZ-2022-01641

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Eano-Euracan-Sno Guidelines on Circumscribed Astrocytic GLIOMAS, Glioneuronal and Neuronaltumors

Rudà, R. ; Capper, D.DKFZ* ; Waldman, A. D. ; Pallud, J. ; Minniti, G. ; Kaley, T. J. ; Bouffet, E. ; Tabatabai, G.DKFZ* ; Aronica, E. ; Jakola, A. S. ; Pfister, S.DKFZ* ; Schiff, D. ; Lassman, A. B. ; Solomon, D. A. ; Soffietti, R. ; Weller, M. ; Preusser, M. ; Idbaih, A. ; Wen, P. Y. ; van den Bent, M. J.

2022
Oxford Univ. Press Oxford

This record in other databases:  

Please use a persistent id in citations: doi:10.1093/neuonc/noac188

Abstract: In the new WHO 2021 Classification of CNS Tumors the chapter “Circumscribed astrocytic gliomas, glioneuronal and neuronal tumors” encompasses several different rare tumor entities, which occur more frequently in children, adolescents and young adults. The Task Force has reviewed the evidence of diagnostic and therapeutic interventions, which is low particularly for adult patients, and draw recommendations accordingly. Tumor diagnosis, based on WHO 2021, is primarily performed using conventional histological techniques; however, molecular workup is important for differential diagnosis, in particular DNA methylation profiling for the definitive classification of histologically unresolved cases. Molecular factors are increasingly of prognostic and predictive importance. MRI finding are non specific, but for some tumors are characteristic and suggestive. Gross total resection, when feasible, is the most important treatment in terms of prolonging survival and achieving long-term seizure control. Conformal radiotherapy should be considered in grade 3 and incompletely resected grade 2 tumors. In recurrent tumors reoperation and radiotherapy, including stereotactic radiotherapy, can be useful. Targeted therapies may be used in selected patients: BRAF and MEK inhibitors in pilocytic astrocytomas, pleomorphic xanthoastrocytomas, and gangliogliomas when BRAF altered, and mTOR inhibitor everolimus in subependymal giant cells astrocytomas .Sequencing to identify molecular targets is advocated for diagnostic clarification and to direct potential targeted therapies.

Note: 2022 Dec 1;24(12):2015-2034

---

Contributing Institute(s):

1. DKTK BE zentral (BE01)
2. DKTK TU zentral (TU01)
3. B062 Pädiatrische Neuroonkologie (B062)
4. DKTK HD zentral (HD01)

Research Program(s):

1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2022

---

Database coverage:
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Essential Science Indicators ; IF >= 10 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---